Interferon‐γ and tumor necrosis factor‐α suppress both early and late stages of hematopoiesis and induce programmed cell death

Journal of Cellular Physiology

Volumn 165, Issue 3, 1995, Pages 538-546

  Selleri, Carmine ^a   Sato, Tadatsugu ^a   Anderson, Stacie ^a   Young, Nel S ^a   Maciejewski, Jaroslaw P ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BONE MARROW DEPRESSION; COLONY FORMATION; DRUG EFFECT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029416957     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041650312     Document Type: Article

References (46)

1. Involvement of interferon‐gamma, and macrophage colony‐stimulating factor in pathogenesis of hemophagocytic lymphohistiocytosis in adults
2. Molecular interaction between interferon consensus sequence binding protein and members of the interferon regulatory factor family
3. Biomolecule‐cell interaction on the regulation of myelopoiesis
4. The suppressive influences of human tumor necrosis factors on bone marrow progenitor cells from normal donors and from patients with leukemia: Synergism of tumor necrosis factor and interferon‐γ
5. Tumor necrosis factor‐alpha strongly potentiates interleukin‐3 and granulocyte‐macrophage colony‐stimulating factor‐induced proliferation of human CD34+ hematopoietic progenitor cells
6. Interferon‐γ enhances factor‐dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells
7. Tumor necrosis factor regulates the expression of granulocyte‐macrophage colony‐stimulating factor and interleukin‐3 receptors on human acute myeloid leukemia cells
8. IFN‐gamma abrogates IL‐7‐dependent proliferation in pre‐B cells, coinciding with onset of apopotsis
9. Interferon‐gamma arrests proliferation and causes apoptosis in stromal cell/interleukin‐7‐dependent normal murine pre‐B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin‐positive B cells
10. Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor
11. Inhibition of S‐phase progression in macrophages is linked to G1/S‐phase suppression of DNA synthesis genes
12. Structure and regulation of the human interferon regulatory factor 1 (IRF‐1) and IRF‐2 genes: Implications for a gene network in the interferon system
13. Comparison of the cytostatic and cytolytic activity of tumor necrosis factor‐alpha and interleukin‐1 alpha in human malignant cell lines
14. Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions
15. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice
16. Increased expression of TNF‐beta in patients with aplastic anemia “abstr”
17. Synergistic effect of recombinant interferon‐γ and interleukin‐3 on the growth of immature human hematopoietic progenitors
18. Involvement of the IRF‐1 transcription factor in antiviral responses to interferons
19. VEHI‐164 clone 2F: In vitro antitumor effects of tumor necrosis factor and gamma‐interferon
20. Immunity afforded by specifically absorbed, unabsorbed and combination of salmonella antisera
21. Inhibition of human erythroid colony‐forming units by tumor necrosis factor requires beta interferon
22. Interferon‐γ gene expression in unstimulated bone marrow mononuclear cells predicts a response to cyclosporine therapy in aplastic anemia
23. γ‐Interferon gene expression in the bone marrow of patients with acquired aplastic anemia
24. Cytostatic and cytotoxic effects of tumor necrosis factor alpha on MCF‐7 human breast tumor cells are differently inhibited by glucocorticoid hormones
25. Clinical toxicity of interferons in cancer patients
26. Studies of interferon as a regulator of hematopoietic cell proliferation
27. The effects of recombinant‐DNA‐derived interferons on the growth of myeloid progenitor cells
28. Tumor necrosis factor‐alpha and hematopoietic progenitors: Effects of tumor necrosis factor on the growth of erythroid progenitors CFU‐E and BFU‐E and the hematopoietic cell line K562, HEL 62, HL60 and HEL cells
29. Abnormal lymphokine production: A novel feature of the genetic disease Fanconi anemia. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha
30. Bifunctional effects of TNF‐alpha on the growth of mature and primitive human hematopoietic progenitor cells
31. Tumor necrosis factor‐alpha inhibits stem cell factor‐induced proliferation of human bone marrow progenitor cells in vitro
32. Recombinant human TNF‐alpha: Preclinical studies and results from early clinical trials
33. Expression and factor‐dependent modulation of the interleukin‐3 receptor subunits on human hematopoietic cells
34. Induction of TNF‐alpha in patients with myelodys‐plastic syndromes undergoing treatment with interleukin‐3
35. Apoptosis in cultured rat hepatocytes: The effect of tumor necrosis factor alpha and interferon gamma
36. + human hematopoietic progenitor cells
37. Characterization and partial purification of human marrow cells capable of initiating long‐term hematopoiesis in vitro
38. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
39. −; progenitor cells
40. Characterization of primitive hematopoietic cells in normal human peripheral blood
41. Effects on leukocytes after injection of tumor necrosis factor into healthy humans
42. Measurement of serum cytokine levels in patients with myelodysplastic syndromes
43. Analysis at the clonal level of T‐cell phenotype and functions in severe aplastic anemia patients
44. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro
45. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo